Prevalence of Type 2 Diabetes Mellitus in Hepatitis C Virus Infected Population: A Southeast Asian Study

Table 2

Unpaired t-test for the mean differences between diabetic and nondiabetic HCV seropositive patients.

Parameters	HCV cases		Mean difference type 2; DM/non diabetic	𝑃 value	95% CI
	Diabetic type 2; 𝑁=114; Mean ± SD	Non Diabetic; 𝑁=247; Mean ± SD
Age—years	49.3±11.0	44.6±12.6	4.71	0.001*	1.38, 7.42
FBS—mg/dL	157.1±47.4	85.8±12.2	71.2	<0.001*	64.9, 77.6
BMI—kg/m^2	27.7±5.48	26.8±5.31	0.99	0.1	−0.20, 2.18
T. Bilirubin—mg/dL	1.67±3.51	1.86±3.83	0.19	0.65	−0.64, 1.02
Prothrombin time	15.9±4.77	15.4±5.22	0.53	0.35	−0.59, 1.66
Albumin—mg/dL	3.22±0.71	3.44±0.68	0.22	0.004*	0.07, 0.37
Cholesterol—mg/dL	200.6±22.4	130.2±16.8	70.4	<0.001*	66.2, 74.6
Creatinine—mg/dL	1.07±0.88	0.82±0.48	0.24	0.001*	0.10, 0.38
Weight—kg	67.8±15.4	64.7±14.0	3.14	0.05	−0.07, 6.36

∗Statistically significant 𝑃 value < 0.05.
FBS: Fasting blood sugar, BMI: Body mass index, CI: Confidence interval.